Jardel Hanna, Rappazzo Kristen M, Luben Thomas J, Keeler Corinna, Staley Brooke S, Ward-Caviness Cavin K, O'Lenick Cassandra R, Rebuli Meghan E, Xi Yuzhi, Hernandez Michelle, Chelminski Ann, Jaspers Ilona, Rappold Ana G, Dhingra Radhika
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina Chapel Hill, Chapel Hill, NC, United States of America.
Oak Ridge Institute for Science and Education (ORISE) Predoctoral Fellow at United States Environmental Protection Agency (US EPA), Research Triangle Park, NC, United States of America.
Environ Res Health. 2024 Dec 1;2(4):045004. doi: 10.1088/2752-5309/ad748c. Epub 2024 Sep 11.
As wildfire frequency and severity increases, smoke exposures will cause increasingly more adverse respiratory effects. While acute respiratory effects of smoke exposure have been documented in children, longer term sequelae are largely unstudied. Our objective here was to examine the association between gestational and postnatal exposure to wildfire smoke and prolonged use of prescription medication for respiratory conditions in early childhood. Using Merative MarketScan claims data, we created cohorts of term children born in western states between 1 January 2010-31 December 2014 followed for at least three years. Using NOAA Hazard Mapping System data, we determined the average number of days a week that >25% of the population in a metropolitan statistical area (MSA) was covered by smoke within each exposure period. The exposure periods were defined by trimester and two 12 week postnatal periods. Medication use was based on respiratory indication (upper respiratory, lower respiratory, or any respiratory condition) and categorized into outcomes of prolonged use (⩾30 d use) (PU) and multiple prolonged uses (at least two prolonged uses) (MPU). We used logistic regression models with random intercepts for MSAs adjusted for child sex, birth season, and birth year. Associations differed by exposure period and respiratory outcome, with elevated risk of MPU of lower respiratory medications following exposure in the third trimester and the first 12 postnatal weeks (RR 1.15, 95% CI 0.98, 1.35; RR 1.21, 95% CI 1.05, 1.40, respectively). Exposure in the third trimester was associated with an increase in MPU of any respiratory among males infants only (male RR 1.22, 95% CI 1.00, 1.50; female RR 0.93, 95% CI 0.66, 1.31). Through novel use of prescription claims data, this work identifies critical developmental windows in the 3rd trimester and first 12 postnatal weeks during which environmental inhalational disaster events may impact longer-term respiratory health.
随着野火发生频率和严重程度的增加,烟雾暴露将导致越来越多的不良呼吸影响。虽然儿童烟雾暴露的急性呼吸影响已有记录,但长期后遗症在很大程度上尚未得到研究。我们在此的目的是研究孕期和产后暴露于野火烟雾与幼儿期因呼吸道疾病长期使用处方药之间的关联。利用默克多市场扫描理赔数据,我们创建了2010年1月1日至2014年12月31日在西部各州出生的足月儿队列,并对其进行了至少三年的随访。利用美国国家海洋和大气管理局(NOAA)灾害绘图系统数据,我们确定了每个暴露期内大都市统计区(MSA)中超过25%的人口被烟雾覆盖的每周平均天数。暴露期按孕期和产后两个12周阶段定义。药物使用基于呼吸道指征(上呼吸道、下呼吸道或任何呼吸道疾病)并分为长期使用(≥30天使用)(PU)和多次长期使用(至少两次长期使用)(MPU)的结果。我们使用了具有随机截距的逻辑回归模型,针对MSA调整了儿童性别、出生季节和出生年份。关联因暴露期和呼吸结果而异,在孕晚期和产后前12周暴露后,下呼吸道药物MPU风险升高(RR分别为1.15,95%CI 0.98,1.35;RR为1.21,95%CI 1.05,1.40)。仅在男性婴儿中,孕晚期暴露与任何呼吸道疾病的MPU增加相关(男性RR为1.22,95%CI 1.00,1.50;女性RR为0.93,95%CI 0.66,1.31)。通过对处方理赔数据的新颖运用,这项研究确定了孕晚期和产后前12周的关键发育窗口期,在此期间环境吸入性灾害事件可能会影响长期呼吸健康。